TETSUO ASHIZAWA to Trinucleotide Repeats
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Trinucleotide Repeats.
Connection Strength
1.316
-
Repeats may not be everything in anticipation. Neurology. 1999 Oct 12; 53(6):1164-5.
Score: 0.161
-
Instability of the (CTG)n repeat in congenital myotonic dystrophy. Am J Hum Genet. 1997 Dec; 61(6):1445-8.
Score: 0.142
-
[Instability of myotonic dystrophy CTG trinucleotide repeat]. Rinsho Shinkeigaku. 1997 Dec; 37(12):1151.
Score: 0.142
-
Instability of the expanded (CTG)n repeats in the myotonin protein kinase gene in cultured lymphoblastoid cell lines from patients with myotonic dystrophy. Genomics. 1996 Aug 15; 36(1):47-53.
Score: 0.130
-
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochem Biophys Res Commun. 2012 Aug 03; 424(3):404-8.
Score: 0.097
-
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet. 2006 Aug 17; 7:71.
Score: 0.065
-
Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10. Neurology. 2006 May 23; 66(10):1602-4.
Score: 0.064
-
Friedreich ataxia in carriers of unstable borderline GAA triplet-repeat alleles. Ann Neurol. 2004 Dec; 56(6):898-901.
Score: 0.058
-
The GAA triplet-repeat sequence in Friedreich ataxia shows a high level of somatic instability in vivo, with a significant predilection for large contractions. Hum Mol Genet. 2002 Sep 01; 11(18):2175-87.
Score: 0.049
-
RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem. 2001 Mar 16; 276(11):7820-6.
Score: 0.044
-
Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells? Mol Psychiatry. 2000 May; 5(3):234-6.
Score: 0.042
-
An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia. Neurology. 2000 Jan 25; 54(2):491-3.
Score: 0.041
-
Getting a grip on the myotonic dystrophies. Neurology. 1999 Jan 01; 52(1):12-3.
Score: 0.038
-
Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology. 1998 Oct; 51(4):1081-6.
Score: 0.038
-
The Initial Symptom and Motor Progression in Spinocerebellar Ataxias. Cerebellum. 2017 06; 16(3):615-622.
Score: 0.034
-
Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet. 1997 May; 60(5):1251-6.
Score: 0.034
-
Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy. Mol Ther. 2016 08; 24(8):1378-87.
Score: 0.032
-
Direct detection of expanded trinucleotide repeats using PCR and DNA hybridization techniques. Am J Med Genet. 1996 Feb 16; 67(1):85-91.
Score: 0.031
-
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet. 2012 Mar 09; 90(3):434-44.
Score: 0.024
-
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
Score: 0.021
-
Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects. Neurology. 2004 Jan 27; 62(2):269-74.
Score: 0.014
-
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 Jan; 15(1):62-9.
Score: 0.008
-
Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet. 1996 Dec 18; 66(3):281-6.
Score: 0.008